Signup Crypto ETF Stocks News

Edesa Biotech Announces Chief Financial Officer Transition - Edesa Biotech ( NASDAQ:EDSA )

TORONTO, April 04, 2025 ( GLOBE NEWSWIRE ) -- Edesa Biotech, Inc. EDSA, a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced the appointment of Peter J. Weiler as Chief Financial Officer, effective May 1, ...

Source: www.benzinga.com
April 04, 2025 | 20:15:46
Category: News

Why Sea Stock Plummeted Today

Shares of Sea Limited ( NYSE: SE ) , the leading e-commerce powerhouse in Southeast Asia, were down 11% as of 3:30 p.m. ET on Friday, according to data provided by S&P Global Market Intelligence.In total this week, Sea's shares have slid 16% as volatility hit the markets after the United States ...

Source: www.fool.com
April 04, 2025 | 20:16:43
Category: News

ThinkCareBelieve: Week 11 America Under President Trump's Leadership

Washington DC, April 04, 2025 ( GLOBE NEWSWIRE ) -- What an amazing week this has been. So many huge strides made. ThinkCareBelieve has published an article about America's Giant Leap into a beautiful new realm of a level playing field with trading partners in global markets with America's ...

Source: www.benzinga.com
April 04, 2025 | 20:22:59
Category: News

This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations - Ayr Wellness ( OTC:AYRWF ) , Ascend Wellness Holdings ( OTC:AAWH )

Strategic mergers & leadership transitions boost market positioning as regulatory updates and policy debates reshape industry dynamics.. New product launches expand consumer offerings in Illinois & beyond.

Source: www.benzinga.com
April 04, 2025 | 20:28:58
Category: News

Beyond Oil Announces Distribution Agreement in the Netherlands with Mandarin Food Products

Partnership Further Expands Beyond Oil's European Footprint as Part of Its Global Growth Strategy Partnership Further Expands Beyond Oil's European Footprint as Part of Its Global Growth Strategy ...

Source: www.globenewswire.com
April 04, 2025 | 20:30:00
Category: News

Eros Resources Closes Oversubscribed $2.1 million Private Placement Financing

Vancouver, BC, April 04, 2025 ( GLOBE NEWSWIRE ) -- Eros Resources Corp. ( TSXV: ROCK ) ( OTCQB: EROSF ) ( "Eros" or the "Company" ) is pleased to announce the closing of its private placement of C$2,077,500 ( the "Financing" ) , which represents an oversubscription of $277,500 of the originally ...

Source: www.globenewswire.com
April 04, 2025 | 20:30:00
Category: News

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635 ( c ) ( 4 )

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 04, 2025 ( GLOBE NEWSWIRE ) -- ORIC Pharmaceuticals, Inc. ( Nasdaq:ORIC ) , a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on April 1, 2025 ( the "Grant ...

Source: www.globenewswire.com
April 04, 2025 | 20:30:00
Category: News

Glacier Bancorp, Inc. Announces First Quarter Earnings Release and Conference Call - Glacier Bancorp ( NYSE:GBCI )

KALISPELL, Mont., April 04, 2025 ( GLOBE NEWSWIRE ) -- Glacier Bancorp, Inc. GBCI will report first quarter financial results after the market closes on April 24, 2025. A conference call for investors is scheduled for 11:00 a.m. Eastern Time on Friday, April 25, 2025.

Source: www.benzinga.com
April 04, 2025 | 20:30:00
Category: News

Glacier Bancorp, Inc. Announces First Quarter Earnings Release and Conference Call

KALISPELL, Mont., April 04, 2025 ( GLOBE NEWSWIRE ) -- Glacier Bancorp, Inc. ( NYSE: GBCI ) will report first quarter financial results after the market closes on April 24, 2025. A conference call for investors is scheduled for 11:00 a.m. Eastern Time on Friday, April 25, 2025.

Source: www.globenewswire.com
April 04, 2025 | 20:30:00
Category: News

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )

WALTHAM, Mass., April 04, 2025 ( GLOBE NEWSWIRE ) -- Xilio Therapeutics, Inc. ( Nasdaq: XLO ) , a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective April 1, 2025, the company ...

Source: www.globenewswire.com
April 04, 2025 | 20:30:00
Category: News

© Natavest 2025 - 2026